Operation Warp Speed Spreads Its Bets With $1.6bn Novavax Deal
Biggest Award Yet, But Strategy Remains Unclear
Novavax has progressed into Phase I trials with relatively little funding, but backing from Operation Warp Speed makes it a stronger contender.
